Filtered By:
Specialty: Drugs & Pharmacology

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 194 results found since Jan 2013.

Mirogabalin: First Global Approval
This article summarizes the milestones in the development of mirogabalin leading to this first approval for PNP.
Source: Drugs - February 19, 2019 Category: Drugs & Pharmacology Source Type: research

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: Definitions, Similarities, and Differences.
Abstract This commentary presents a simplified way of making the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) using the 1994 Centers for Disease Control and Prevention case definition. The format used can easily be modified for other case definitions. The commentary then discusses whether ME/CFS is the same or a different illness from fibromyalgia. Because overlap exists between the 2 syndromes, some investigators have posited that they are variants of the same illness. I have viewed this as an empirically testable hypothesis and have summoned considerable amounts of data that suggest t...
Source: Clinical Therapeutics - February 19, 2019 Category: Drugs & Pharmacology Authors: Natelson BH Tags: Clin Ther Source Type: research

Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review
Publication date: January 2019Source: Biomedicine & Pharmacotherapy, Volume 109Author(s): Kholoud M. El-Shewy, Ahmad Kunbaz, Mohamed M. Gad, Muneer J. Al-Husseini, Anas M. Saad, Yasser M. Sammour, Mohamed M. Abdel-DaimAbstractChronic pain is one of the most common clinical presentations in the primary care settings. In the US, Fibromyalgia (FM) affects about 1–3% of adults and commonly occurs in adults between the ages of 40–50 years. FM causes widespread muscular pain and tenderness with hyperalgesia and allodynia and may be associated with other somatic complaints.Hyperbaric oxygen therapy (HBOT) has been utilized an...
Source: Biomedicine and Pharmacotherapy - November 4, 2018 Category: Drugs & Pharmacology Source Type: research

Hyperbaric oxygen and aerobic exercise in the long-term treatment of fibromyalgia: A narrative review.
Abstract Chronic pain is one of the most common clinical presentations in the primary care settings. In the US, Fibromyalgia (FM) affects about 1-3% of adults and commonly occurs in adults between the ages of 40-50 years. FM causes widespread muscular pain and tenderness with hyperalgesia and allodynia and may be associated with other somatic complaints. Hyperbaric oxygen therapy (HBOT) has been utilized and has recently shown promising effects in the management of FM and other chronic pain disorders. In HBOT, the intermittent breathing of 100% oxygen in a pressurized chamber where the pressure is higher than 1 at...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - November 3, 2018 Category: Drugs & Pharmacology Authors: El-Shewy KM, Kunbaz A, Gad MM, Al-Husseini MJ, Saad AM, Sammour YM, Abdel-Daim MM Tags: Biomed Pharmacother Source Type: research

Oral Fluoroquinolones and Risk of Fibromyalgia
British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.
Source: British Journal of Clinical Pharmacology - September 14, 2018 Category: Drugs & Pharmacology Authors: SaeedGanjizadeh ‐ZavarehMD, MHSc , MohitSodhiBSc , ToriSpangehlBSN , BruceCarletonPharmD , MahyarEtminanPharmD Source Type: research

Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders?
Abstract Opioids have been used for centuries, mostly as a sedative and to treat pain. Currently, they are used on a global scale for the treatment of acute and chronic pain in diseases as osteoarthritis, fibromyalgia, and low back pain. Binding of opioids on opioid receptors can cause a range of different effects such as changes in stress response, analgesia, motor activity and autonomic functions. This review provide a synthetic summary of the most recent literature on the use of drugs acting on mu-receptors to treat two prevalent functional bowel disorders, presenting with opposite bowel habit. Eluxadoline and ...
Source: Current Opinion in Pharmacology - September 3, 2018 Category: Drugs & Pharmacology Authors: Pannemans J, Corsetti M Tags: Curr Opin Pharmacol Source Type: research

Endogenous systems involved in exercise-induced analgesia.
Authors: Da Silva Santos R, Galdino G Abstract Exercise-induced analgesia is a phenomenon discussed worldwide. This effect began to be investigated in the early 1970s in healthy individuals and rodents during and after an acute or chronic session of running or swimming. Thereafter, studies found this effect was also induced by resistance exercises. Over the years, many studies have demonstrated the importance of exercise-induced analgesia in relieving pain caused by different conditions, such as fibromyalgia, low back pain, neuropathy, and osteoarthritis. This review aims to provide the reader with an in-depth desc...
Source: Journal of Physiology and Pharmacology - May 19, 2018 Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research

Fibromyalgia and nutrition: Therapeutic possibilities?
Publication date: July 2018 Source:Biomedicine & Pharmacotherapy, Volume 103 Author(s): Geir Bjørklund, Maryam Dadar, Salvatore Chirumbolo, Jan Aaseth Fibromyalgia (FM) is a complex chronic condition of unknown etiology, characterized by deep and widespread pain, sleep problems, cognitive impairment, fatigue, and other well-known functional symptoms. Recently, it has been proposed that an imbalance of nutritive components, including essential metal ions and vitamins, might play a critical role in the development of FM. Muscle pain has been associated with deficiencies in amino acids, magnesium, selenium, vitamins...
Source: Biomedicine and Pharmacotherapy - April 25, 2018 Category: Drugs & Pharmacology Source Type: research

Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies
Conclusion The study underscores the need for regulatory efforts to manage pregabalin abuse, through the addition of pregabalin containing products to the controlled drug list which can’t be purchased without a prescription. Also, pharmacists and customers must be educated at a community pharmacy level regarding potential hazards of pregabalin abuse.
Source: Saudi Pharmaceutical Journal - March 26, 2018 Category: Drugs & Pharmacology Source Type: research

Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia.
We examined the effects of pregabalin and duloxetine, drugs approved for fibromyalgia treatment, on the levels of extracellular neurotransmitters in the dorsal horn of the spinal cord in RIM rats using microdialysis. Male SD rats were used for all experiments. To generate RIM rats, reserpine was injected at 1mg/kg subcutaneously once daily for three consecutive days. The pressure threshold of the mid-gastrocnemius muscle was measured using a Randall-Selitto apparatus. Norepinephrine, dopamine, and serotonin were detected using high-performance liquid chromatography with electrochemical detection, and glutamate and γ-amino...
Source: European Journal of Pharmacology - March 9, 2018 Category: Drugs & Pharmacology Authors: Kiso T, Moriyama A, Furutani M, Matsuda R, Funatsu Y Tags: Eur J Pharmacol Source Type: research

Ginger rhizome enhances the anti-inflammatory and anti-nociceptive effects of paracetamol in an experimental mouse model of fibromyalgia
This study was designed to compare the anti-nociceptive and anti-inflammatory effect of dried powdered ginger rhizome (GR) and paracetamol (APAP) on an experimental mouse model of fibromyalgia syndrome (FMS) induced by intermittent cold stress (ICS).MethodsForty-eight female C57BL/6  J mice were used for the experiments. The animals were allocated in six groups (n = 8). Each group received one of the following treatments for 8 weeks: healthy control, ICS group, ICS + APAP (40 mg/Kg/day), ICS + GR (0.5%); ICS + GR (1%), and ICS + GR (0.5%) + APAP (40 mg/Kg/day). After treatment, symptoms of FMS were induced ...
Source: Inflammopharmacology - February 8, 2018 Category: Drugs & Pharmacology Source Type: research

The Safety and Efficacy of Low ‐Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,Volume 38, Issue 3, Page 382-389, March 2018.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - January 27, 2018 Category: Drugs & Pharmacology Source Type: research

The safety and efficacy of low ‐dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders
This article is protected by copyright. All rights reserved.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - January 1, 2018 Category: Drugs & Pharmacology Authors: Denise K. Patten, Bob G. Schultz, Daniel J. Berlau Tags: Review of Therapeutics Source Type: research

An update on emerging drugs for fibromyalgia treatment.
AN UPDATE ON EMERGING DRUGS FOR FIBROMYALGIA TREATMENT. Expert Opin Emerg Drugs. 2017 Dec 18;: Authors: Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P Abstract INTRODUCTION: Fibromyalgia (FM) is a chronic disorder whose symptoms of pain, fatigue, sleep disturbances and depression have a devastating effect on patients' lives as it limits their ability to engage in everyday working and social activities, and make it difficult to maintain normal relationships with family, friends and employers. None of the currently available drugs are fully effective against the whole spectru...
Source: Expert Opinion on Emerging Drugs - December 20, 2017 Category: Drugs & Pharmacology Tags: Expert Opin Emerg Drugs Source Type: research